| Preliminary Program | ||
Wednesday April 30
|
Thursday May 1
|
Electronic Posters
|
| Wednesday, April 30, 2014 | ||
| 07:45 | Registration | |
| 08:30-10:30 | Parallel Sessions | |
| Intensive Care-Contemporary Management of STEMI Rehabilitation, Epidemiology, Prevention and Risk Factors/ Pharmacotherapy Interventional Cardiology-TAVI1 Echocardiography: Valvular Heart Disease Ami Cohen Award -Cardiovascular Surgery Heart Failure Pacing and Electrophysiology-Clinical EP Ablations Basic Science |
||
| 10:30-11:00 | Coffee Break, Exhibition & E-Posters Visit | |
| 11:00-12:50 |
Plenary Session I- Opening Ceremony |
|
|
Greetings Neufeld Memorial Lectures: |
||
| A Critical Review of the ESC/EACTS Guidelines on the Management of Valvular Disease Two Years after the Publication Alec Vahanian Bichat University Hospital, Paris, France |
||
| Clinical Research and the Development of Medical Therapeutics Elliott Antman President-Elect, American Heart Association, Brigham and Women’s Hospital, Boston, USA |
||
| 12:50-14:50 | Lunch & Lunch Sessions, Exhibition & E-Posters Visit | |
| 12:50-14:50 | Lunch – Annual Business Meeting of the Israeli Society of Cardiothoracic Surgery | |
| 12:55-14:45 | LS1-Lunch Session-Sponsored by – Medtronic | |
| Place of Minimal Invasive Technologies in Patients Continuum of Care | ||
|
Chairs: Michael Glikson; Amit Segev, Israel Optimizing Outcomes for the Endovascular Repair of Type B Dissection The Role of Minimally Invasive ICMs in Arrhythmia Diagnosis and Management Benefits of Ablation vs. Medication for the Treatment of Atrial Fibrillation CoreValve US Pivotal Trial High Risk Study Results |
||
| 12:55-14:45 | LS2-Lunch Session-Sponsored by – Pfizer | |
| Patient Tailored Approach in Anti-coagulation treatment – Decision Making in AFib | ||
|
Chairs: TBA TBA TBA TBA |
||
| 12:55-14:45 | LS3-Lunch Session – Sponsored by – AstraZeneca | |
| Novel Antiplatelet Agents for the Treatment of STEMI Patients | ||
|
Chairs: TBA The Effect of Ticagrelor in ACS – Platelet and Non Platelet Dependent Mechanisms Why do I Use Ticagrelor in STEMI Patients Panel Discussion: Panel Members: Giora Weisz, Ronen Rubinstien, Zaza Iakobishvili |
||
| 14:50-16:45
|
Plenary Session II | |
| Plenary Joint Session with the American College of Cardiology and the Israel Heart Society | ||
| 25 Years of Endothelial Studies in Humans: Where We Have Been and Where We Are Heading Peter Ganz Center of Excellence in Vascular Research, San Francisco General Hospital, University of California, San Francisco, California, USA |
||
| The Challenge of Low Flow Low Gradient Aortic Stenosis Patrick T. O’Gara President American College of Cardiology |
||
| The Digital Revolution in Cardiology John G. Harold President, American College of Cardiology, Cedars-Sinai Medical Center, Los Angeles, LA, USA |
||
| Therapeutic Options in Patients with Refractory Angina Shmuel Banai Tel-Aviv Sourasky Medical Center, Cardiology, Tel-Aviv, Israel |
||
| Optimizing Antiplatelet Therapy in Diabetes Mellitus Dominick J. Angiolillo University of Florida College of Medicine-Jacksonville, California, USA |
||
| Q & A | ||
| 16:45-17:00 | Coffee Break, Exhibition & E-Posters Visit | |
| 17:00-18:30 | Parallel Sessions |
|
| Intensive Care-Clinical Aspects of Acute Myocardial Infarction Rehabilitation, Epidemiology, Prevention and Risk Factors/ Pharmacotherapy Interventional Cardiology- TAVI2 Pacing and Electrophysiology-Clinical Pacing Cardiovascular Surgery Heart Failure/ Myocardial/Pericardial Diseases-Non Invasive Monitoring in Heart Failure Cardiac Imaging Jan J. Kellermann Young Investigator Cardiology Awards |
||
| Thursday, May 1, 2014 | ||
| 07:45 | Registration | |
| 08:30-10:00 | Parallel Sessions | |
| Special Session in Memory of Richard S. Meltzer, MD Rehabilitation, Epidemiology, Prevention and Risk Factors/ Pharmacotherapy Interventional Cardiology- Coronary Cardiovascular Surgery Joint Session: AFICARDIO- Challenges in Sports Medicine in Cardiology Pacing and Electrophysiology-Basic Science Basic Science Pediatric Cardiology |
||
| 10:00-10:30 | Coffee Break, Exhibition & E-Posters Visit | |
| 10:30-12:50 | Plenary Session III | |
| Joint Session with the European Society of Cardiology | ||
| Scholarship & Awards of the Israel Heart Society | ||
| Jan J. Kellermann Young Investigator in Cardiology Awards | ||
| Michael Mirowski Excellence in Cardiology Award | ||
| Richard, Hilda and Ezra Meltzer Memorial Award | ||
| Daniel Shiran Outstanding Cardiology Resident Award | ||
| Best Publication & Abstract Awards | ||
| Mayo Clinic Fellowship Award | ||
| Merck Fellowship Awards | ||
| Orbotech Fellowship Award | ||
| Trireme Fellowship Award | ||
| Scholarship & Awards of the Israeli Society Cardiothoracic Surgery | ||
| Ami Cohen Young Investigator in Cardiac Surgery Awards | ||
| Hanoch Milwidsky Outstanding Cardiac Surgery Resident Awards | ||
| HDC-Dysfunction: Is Raising HDL-C Still a Therapeutic Option? Thomas F. Lüscher Editor-in-Chief, European Heart Journal, University Heart Center, Zurich, |
||
| SwitzerlandMultimodality Imaging in Coronary Artery Disease Fausto J. Pinto President- Elect, European Society of Cardiology, Lisbon Cardiovascular Institute, Lisbon, Portugal |
||
| CABG and PCI in 2014: Practice and Politics David Taggart University of Oxford, England |
||
| “Genes, Cells, Cardiology” Moshe Flugelman Carmel Medical Center, Haifa, Israel |
||
| 12:50-14:45 | Lunch & Lunch Sessions, Exhibition & E-Posters Visit | |
| 12:55-14:40 | LS4- Lunch Session – Sponsored by – Rafa Labs | |
| Multidisciplinary Approach in Stroke Prevention in Atrial Fibrillation | ||
|
||
| 12:55-14:40 | LS5-Lunch Session Sponsored by – Lilly | |
| How to Optimally Tailor Antiplatelet Therapy in Patients with NSTEMI | ||
| Chairs: Dominick J. Angiolillo, USA; Shlomi Matezky; Ariel Rugin, IsraelHow to OptimallyTailor Antiplatelet Therapy in Patients with NSTEMI: What have we learned?Dominick J. Angiolillo, University of Florida College of Medicine, Jacksonville, CA, USACase PresentationPanel Discussion | ||
| 12:55-14:40 | LS6-Lunch Session – Sponsored by Itamar Medical | |
| Endothelial Function Assessment – Ready for Clinical Use | ||
| In the Management of CV Risk Michael Shechter Chaim Sheba Medical Center, Tel Hashomer, Israel |
||
| As an Additional Marker to Target in Secondary Prevention Amir Lerman Mayo Clinic, Rochester, USA |
||
| Sleep Apnea Endothelial Dysfunction Association – Targeting the Two makes it Even Better Giora Pillar Carmel Medical Center, Haifa, Israel |
||
| 14:00-15:50 | Special Session- Pediatric Cardiology | |
| 14:45-15:45 | Parallel Sessions | |
| Intensive Care-Antiplatelet Therapy: Clinical and Laboratory Aspects Rehabilitation, Epidemiology, Prevention and Risk Factors/ Pharmacotherapy Interventional Cardiology Cardiovascular Surgery-EC Myocardial / Pericardial Diseases, Heart Failure-Invasive Approaches to Heart Failure Joint Session – Society of Cardiovascular Computed Tomography (SCCT) and Israel Heart Society Echocardiography and Valvular Diseases |
||
| 15:45-16:00 | Coffee Break, Exhibition & E-Posters Visit, Exhibition | |
| 16:00-17:45 | Parallel Sessions | |
| Intensive Cardiac Care Rehabilitation, Epidemiology, Prevention and Risk Factors/ Pharmacotherapy Interventional Cardiology-TAVI & Structural Pacing and Electrophysiology- Clinical Myocardial Diseases Echocardiography and Miscellaneous Basic Science |
||
| 17:45-18:30 | Annual General Assembly of the Israel Heart Society | |
